The reduction of TAK1 prevents lung inflammation in pneumoconiosis and reduces monosodium urate-induced inflammation as well as obesity-linked inflammation18,27,28; however, its biological function was little reported in neurological lesion especially in SCI. Here, MAP3K7 is linked to obesity due to melanocortin 4 receptor deficiency.